ABT
Abbott Laboratories
ABT's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over ABT overall, supported by stronger modeled upside and stronger valuation.
ABT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Under pressure |
ABT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ABT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $107 | — |
| Cheap | 22x | $58.67 | -45% |
| Fair | 33x | $88.57 | -17% |
| Current | 40x | $107 | — |
| Expensive | 45x | $121 | +13% |
Historical ranges are pointers, not guarantees.
ABT's PE is in its expensive range at 40x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH has the edge over ABT in the historical PE scenario, which offers more potential upside but is not a forecast.
ABT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for ABT, with profitability holding steady.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ABT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.84 | +118% |
| Q3 2026 | $2.68 | -66% |
| Q2 2026 | $3.09 | -61% |
| Q1 2026 | $3.57 | -54% |
| Q4 2025 | $3.72 | -51% |
| Q3 2025 | $7.97 | +142% |
| Q2 2025 | $7.97 | +151% |
| Q1 2025 | $7.70 | +140% |
| Q4 2024 | $7.64 | +134% |
ABT has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
ABT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13B | +14% |
| Q2 2026 | $12.6B | +13% |
| Q1 2026 | $11.2B | +7.8% |
| Q4 2025 | $11.5B | +4.4% |
| Q3 2025 | $11.4B | +6.9% |
| Q2 2025 | $11.1B | +7.4% |
| Q1 2025 | $10.4B | +4% |
| Q4 2024 | $11B | +7.2% |
ABT's revenue has grown year over year for 12 quarters in a row: $13B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -7.7 points |
| Q2 2026 | 13% | -5 points |
| Q1 2026 | 12% | -4.3 points |
| Q4 2025 | 20% | +2.2 points |
| Q3 2025 | 18% | +0.6 points |
| Q2 2025 | 18% | +2.3 points |
| Q1 2025 | 16% | +2.4 points |
| Q4 2024 | 17% | 0 points |
ABT has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ABT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | -47% |
| Q2 2026 | $2B | +29% |
| Q1 2026 | $916M | -1.8% |
| Q4 2025 | $2.6B | +22% |
| Q3 2025 | $2.3B | +6.6% |
| Q2 2025 | $1.5B | +8.3% |
| Q1 2025 | $933M | +49% |
| Q4 2024 | $2.1B | -5.9% |
ABT's free cash flow has been positive every quarter for seven years: $6.8B over the past year, down 2.3% from the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
ABT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -5.1M shares |
| 1 year | -0.7% | -11.5M shares |
| 3 years | -0.6% | -10.4M shares |
| 5 years | -2.9% | -51.1M shares |
| Available history | -2.4% | -43.1M shares |
ABT has 1.7B diluted shares, down 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $11M |
| Q2 2026 | $1B |
| Q1 2026 | $180M |
| Q4 2025 | $302M |
| Q3 2025 | $305M |
| Q2 2025 | $6M |
| Q1 2025 | $280M |
| Q4 2024 | $315M |
ABT spent $1.5B buying back its own shares over the past year, up 70% from the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ABT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.7x | Very low |
ABT's net debt is about 2.6 years of its operating earnings (EBITDA), up from less than a year a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over ABT on leverage, with a lower net debt burden relative to earnings.
ABT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 57.1 | Neutral |
ABT's weekly RSI is 54 (neutral) and its Stochastic is 57 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ABT PE vs Healthcare Sector
| Metric | ABT | Sector median | Relative |
|---|---|---|---|
| PE | 40x | 26x | 55% above |
| PE % | 81 | 29 | 52 pts above |
ABT is trading at 40x earnings, a 55% premium to the Healthcare sector's median of 26x.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over ABT on valuation relative to its sector.
ABT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $103.8 | 3.3% above |
| 20 week MA | $104.5 | 2.6% above |
| 50 week MA | $104.9 | 2.3% above |
| 100 week MA | $117.0 | 8.4% below |
| 200 week MA | $112.4 | 4.6% below |
ABT has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 4.6% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ABT on trend strength, trading above more of its moving averages.
ABT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $87.4 | $108.4 | +24% |
| 2021 | $108.4 | $139.2 | +28% |
| 2022 | $139.2 | $108.2 | -22% |
| 2023 | $108.2 | $110.1 | +1.7% |
| 2024 | $110.1 | $115.0 | +4.5% |
| 2025 | $115.0 | $124.8 | +8.6% |
| 2026 YTD | $124.8 | $107.3 | -14% |
ABT has finished higher in five of the last six years. It's down 14% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ABT on returns for 2026, with the stronger performance.